Prenatal Corticosteroids and Antioxidants in Preterm Infants

NCT00791687 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2008-11-14

No results posted yet for this study

Summary

Premature infants are highly susceptible to oxidative stress because of the immaturity of their antioxidant defense system. The use of prenatal glucocorticosteroids administered to the mother improves respiratory function and overall outcome. The investigators hypothesize that prenatal glucocorticosteroids favor the expression and competence of the antioxidant defense system.

Conditions

  • Oxidative Stress

Sponsors & Collaborators

  • University of Valencia

    collaborator OTHER
  • Carlos III Health Institute

    collaborator OTHER_GOV
  • Fundacion Para La Investigacion Hospital La Fe

    lead OTHER

Principal Investigators

  • MAXIMO VENTO, PHD, MD · Valencian Agency of Health

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2005-01-31
Completion
2005-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00791687 on ClinicalTrials.gov